Your browser doesn't support javascript.
loading
Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion.
Liu, Yi; Deguchi, Yasunori; Tian, Rui; Wei, Daoyan; Wu, Ling; Chen, Weidong; Xu, Weiguo; Xu, Min; Liu, Fuyao; Gao, Shen; Jaoude, Jonathan C; Chrieki, Sarah P; Moussalli, Micheline J; Gagea, Mihai; Morris, Jeffrey; Broaddus, Russell R; Zuo, Xiangsheng; Shureiqi, Imad.
Afiliação
  • Liu Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Deguchi Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tian R; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wei D; Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Wu L; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen W; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Xu W; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Xu M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liu F; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gao S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jaoude JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chrieki SP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Moussalli MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gagea M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Morris J; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Broaddus RR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zuo X; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shureiqi I; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ishureiqi@mdanderson.org xzuo@mdanderson.org.
Cancer Res ; 79(5): 954-969, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30679176
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptores Citoplasmáticos e Nucleares / PPAR delta Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptores Citoplasmáticos e Nucleares / PPAR delta Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article